## Record Q3 print: not just “AI demand” — it’s a step-function in monetization Credo’s latest disclosed results show a clear acceleration in its AI connectivity franchise: fiscal Q3 2026 revenue of **$407.0M** (+**51.9% Q/Q**, +**201.5% Y/Y**) with **non‑GAAP EPS of $1.07** and **non‑GAAP net income of $208.8M**. ["Revenue of $407.0 million"](0001628280-26-013205|1) ["grew by 51.9% quarter over quarter"](0001628280-26-013205|1) ["201.5% year over year"](0001628280-26-013205|1) ["non-GAAP diluted net income per share of $1.07"](0001628280-26-013205|1) ["non-GAAP net income of $208.8 million"](0001628280-26-013205|1) **Between the lines:** the magnitude of the Q/Q jump suggests Credo is not merely participating in AI capex—it is landing into *urgent buildouts* where throughput, power, and time-to-deploy trump vendor churn. Management explicitly framed the quarter as “record results” alongside continued growth in **AECs and ICs**, which reads like breadth across both “attach” and “silicon” content per deployment. ["delivered record results"](0001628280-26-013205|1) ["continued growth in AECs and ICs"](0001628280-26-013205|1) ## Margin quality + operating leverage: the model is scaling faster than the P&L “should” Q3 non‑GAAP gross margin was **68.6%**, and the company posted **non‑GAAP operating income margin of 49.6%** (vs **46.3%** in the prior quarter), i.e., about **+330 bps sequential expansion (computed)**. ["Non-GAAP gross margin | 68.6"](0001628280-26-013205|1) ["Non-GAAP operating income margin | 49.6"](0001628280-26-013205|1) ["Non-GAAP operating income margin | 46.3"](0001628280-26-013205|1) **Between the lines:** when operating margin expands *while* revenue is up ~52% Q/Q, it’s a tell that Credo is moving through a scale threshold—mix plus absorption are working in its favor, and incremental gross profit is translating disproportionately into operating profit. That is the kind of operating leverage that can persist longer than consensus models typically assume during infrastructure ramps (until supply or mix flips). ## Q4 outlook: revenue still stepping up, but gross margin guide hints at deliberate conservatism For fiscal Q4 2026, Credo guided revenue to **$425M–$435M**, which implies roughly **+4.4% to +6.9% sequential growth vs. Q3 (computed)**. ["Revenue is expected to be between $425.0 million and $435.0 million"](0001628280-26-013205|1) ["Revenue | 407,012"](0001628280-26-013205|1) At the same time, non‑GAAP gross margin is guided to **64.0%–66.0%**, down from Q3’s **68.6%**. ["non-GAAP gross margin is expected to be between 64.0% and 66.0%"](0001628280-26-013205|1) ["Non-GAAP gross margin | 68.6"](0001628280-26-013205|1) **Between the lines:** the combination of (1) continued revenue growth and (2) a notably lower GM guide often signals management is *choosing* conservatism around near-term product/customer mix or ramp costs—potentially while staying aggressive on securing sockets. Put differently, the Q4 guide reads less like demand risk and more like a prudently framed “mix transition quarter” while the company continues to push into larger AI buildouts. ## TAM expansion language is doing real work here (and the balance sheet gives it time) Management emphasized “three new multi‑billion dollar TAM expansions” through **ZeroFlap optics, ALCs, and OmniConnect**. ["three new multi-billion dollar TAM expansions"](0001628280-26-013205|1) ["ZeroFlap optics, ALCs, and OmniConnect"](0001628280-26-013205|1) Credo also disclosed an **ending cash and short‑term investment balance of $1.3B**, with the balance sheet showing **$1.22B of cash and cash equivalents** at quarter-end. ["Ending cash and short-term investment balance of $1.3 billion"](0001628280-26-013205|1) ["Cash and cash equivalents | $ 1,220,464"](0001628280-26-013205|1) **Between the lines:** the TAM-expansion messaging paired with a $1B+ liquidity position is a “permission slip” to invest into adjacent attach points (optical, memory connectivity, new architectures) without needing to optimize for quarter-to-quarter funding. That matters because platform shifts in AI interconnect are as much about *time-in-market* and customer validation cycles as they are about raw silicon performance. ## The underwritten risk: concentration remains structurally high In its most recent Form 10‑Q (fiscal Q2 2026), Credo reiterated that a “relatively small number of customers” account for a “significant portion” of revenue and even provided **end-customer concentration** (e.g., one end customer at **42%** and another at **24%** of revenue for the quarter ended Nov. 1, 2025). ["a relatively small number of customers"](0001628280-25-054549|0) ["significant portion of the Company’s revenue"](0001628280-25-054549|0) ["Customer C | 42 | %"](0001628280-25-054549|0) ["Customer D | 24 | %"](0001628280-25-054549|0) **Between the lines:** this is the “price of admission” for hyperscaler-led cycles—Credo can compound quickly when it wins the right buildout, but the equity will also trade on procurement decisions and architecture shifts at a handful of customers. --- ### Disclosure gap vs. your draft (important) Your draft includes specific claims (e.g., **FY27 revenue >50% Y/Y**, “optics ramp pulled forward,” “top three hyperscalers 39%/32%/17%,” and the **CoMira Solutions** acquisition) that **do not appear in the latest SEC disclosures I pulled** (March 2, 2026 earnings 8‑K/press release; Feb. 9, 2026 pre-release update; and the latest filed 10‑Q). If you want, paste the source (earnings call transcript / investor deck / press release link), and I’ll rewrite the same framework anchored to that disclosure set as well. ["Press Release dated March 2, 2026"](0001628280-26-013205|0) ["updated revenue guidance"](0001628280-26-006370|1)

## Record Q3 print: not just “AI demand” — it’s a step-function in monetization Credo’s latest disclosed results show a clear acceleration in its AI connectivity franchise: fiscal Q3 2026 revenue of **$407.0M** (+**51.9% Q/Q**, +**201.5% Y/Y**) with **non‑GAAP EPS of $1.07** and **non‑GAAP net income of $208.8M**. ["Revenue of $407.0 million"](0001628280-26-013205|1) ["grew by 51.9% quarter over quarter"](0001628280-26-013205|1) ["201.5% year over year"](0001628280-26-013205|1) ["non-GAAP diluted net income per share of $1.07"](0001628280-26-013205|1) ["non-GAAP net income of $208.8 million"](0001628280-26-013205|1) **Between the lines:** the magnitude of the Q/Q jump suggests Credo is not merely participating in AI capex—it is landing into *urgent buildouts* where throughput, power, and time-to-deploy trump vendor churn. Management explicitly framed the quarter as “record results” alongside continued growth in **AECs and ICs**, which reads like breadth across both “attach” and “silicon” content per deployment. ["delivered record results"](0001628280-26-013205|1) ["continued growth in AECs and ICs"](0001628280-26-013205|1) ## Margin quality + operating leverage: the model is scaling faster than the P&L “should” Q3 non‑GAAP gross margin was **68.6%**, and the company posted **non‑GAAP operating income margin of 49.6%** (vs **46.3%** in the prior quarter), i.e., about **+330 bps sequential expansion (computed)**. ["Non-GAAP gross margin | 68.6"](0001628280-26-013205|1) ["Non-GAAP operating income margin | 49.6"](0001628280-26-013205|1) ["Non-GAAP operating income margin | 46.3"](0001628280-26-013205|1) **Between the lines:** when operating margin expands *while* revenue is up ~52% Q/Q, it’s a tell that Credo is moving through a scale threshold—mix plus absorption are working in its favor, and incremental gross profit is translating disproportionately into operating profit. That is the kind of operating leverage that can persist longer than consensus models typically assume during infrastructure ramps (until supply or mix flips). ## Q4 outlook: revenue still stepping up, but gross margin guide hints at deliberate conservatism For fiscal Q4 2026, Credo guided revenue to **$425M–$435M**, which implies roughly **+4.4% to +6.9% sequential growth vs. Q3 (computed)**. ["Revenue is expected to be between $425.0 million and $435.0 million"](0001628280-26-013205|1) ["Revenue | 407,012"](0001628280-26-013205|1) At the same time, non‑GAAP gross margin is guided to **64.0%–66.0%**, down from Q3’s **68.6%**. ["non-GAAP gross margin is expected to be between 64.0% and 66.0%"](0001628280-26-013205|1) ["Non-GAAP gross margin | 68.6"](0001628280-26-013205|1) **Between the lines:** the combination of (1) continued revenue growth and (2) a notably lower GM guide often signals management is *choosing* conservatism around near-term product/customer mix or ramp costs—potentially while staying aggressive on securing sockets. Put differently, the Q4 guide reads less like demand risk and more like a prudently framed “mix transition quarter” while the company continues to push into larger AI buildouts. ## TAM expansion language is doing real work here (and the balance sheet gives it time) Management emphasized “three new multi‑billion dollar TAM expansions” through **ZeroFlap optics, ALCs, and OmniConnect**. ["three new multi-billion dollar TAM expansions"](0001628280-26-013205|1) ["ZeroFlap optics, ALCs, and OmniConnect"](0001628280-26-013205|1) Credo also disclosed an **ending cash and short‑term investment balance of $1.3B**, with the balance sheet showing **$1.22B of cash and cash equivalents** at quarter-end. ["Ending cash and short-term investment balance of $1.3 billion"](0001628280-26-013205|1) ["Cash and cash equivalents | $ 1,220,464"](0001628280-26-013205|1) **Between the lines:** the TAM-expansion messaging paired with a $1B+ liquidity position is a “permission slip” to invest into adjacent attach points (optical, memory connectivity, new architectures) without needing to optimize for quarter-to-quarter funding. That matters because platform shifts in AI interconnect are as much about *time-in-market* and customer validation cycles as they are about raw silicon performance. ## The underwritten risk: concentration remains structurally high In its most recent Form 10‑Q (fiscal Q2 2026), Credo reiterated that a “relatively small number of customers” account for a “significant portion” of revenue and even provided **end-customer concentration** (e.g., one end customer at **42%** and another at **24%** of revenue for the quarter ended Nov. 1, 2025). ["a relatively small number of customers"](0001628280-25-054549|0) ["significant portion of the Company’s revenue"](0001628280-25-054549|0) ["Customer C | 42 | %"](0001628280-25-054549|0) ["Customer D | 24 | %"](0001628280-25-054549|0) **Between the lines:** this is the “price of admission” for hyperscaler-led cycles—Credo can compound quickly when it wins the right buildout, but the equity will also trade on procurement decisions and architecture shifts at a handful of customers. --- ### Disclosure gap vs. your draft (important) Your draft includes specific claims (e.g., **FY27 revenue >50% Y/Y**, “optics ramp pulled forward,” “top three hyperscalers 39%/32%/17%,” and the **CoMira Solutions** acquisition) that **do not appear in the latest SEC disclosures I pulled** (March 2, 2026 earnings 8‑K/press release; Feb. 9, 2026 pre-release update; and the latest filed 10‑Q). If you want, paste the source (earnings call transcript / investor deck / press release link), and I’ll rewrite the same framework anchored to that disclosure set as well. ["Press Release dated March 2, 2026"](0001628280-26-013205|0) ["updated revenue guidance"](0001628280-26-006370|1)